REALTIME HIV-1 VIRAL LOAD (CE)

CE Marked                                                      

For In Vitro Diagnostic Use

The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) in whole blood spotted on cards as dried blood spots (DBS) (i.e. obtained via venipuncture or capillary blood) or human plasma from HIV-1 infected individuals.

Precise performance when meeting HIV challenges

The Abbott RealTime HIV-1 assay provides:

  • Enhanced precision: Provides strong performance measuring low-level viremia
  • Accurate monitoring: Confidence to reliably detect changes to patient's response status
  • Unique assay design: Partially double stranded probe, highly conserved target region and specific temperature profile ensure reliable detection of all groups and subtypes

Addressing the Challenges of HIV

The Abbott RealTime HIV-1 assay is engineered to address the challenges of HIV:

The genetic heterogeneity of HIV-1 presents a significant challenge to the development of assays capable of reliably detecting and quantifying HIV-1 nucleic acid. Although certain subtypes dominate in specific areas, studies show that the spread of different HIV-1 groups and subtypes is increasing globally.

HIV-1 diversity can be attributed to:

  • Error-prone reverse transcriptase enzyme
  • Recombination of subtypes
  • Cross-specific transmission 

Physiological Blip or Random Assay Variation?

A detectable low-level viremia following a previous viral load below the limit of detection or undetectable may be:  

  • A true increase of the viral load level, such as the first step toward the development of resistance 
  • A physiological blip caused by e.g. release of virus from a reservoir 
  • An assay artifact measurement such as random variations (imprecision) around the decision point 

Each HIV-1 positive viral load result can generate anxiety among both clinicians and patients concerning the adequacy of therapy. In cases where these results are driven by random assay variation this may lead to unnecessary additional testing.

Abbott RealTime HIV-1 assay demonstrates high precision around the clinical decision point and minimizes the risk of reporting a low-level viremia result due to random assay variation.

hiv-quantificatioin-comparision-chart image

The coefficient of variation observed in low viral load patient specimens (three patient samples with viral load below 100 coples/mL; 10 replicates each, was significantly lower with Abbott RealTime HIV (26%-31%) than that of a comparator assay (37-59%).
 

Detection of HIV-1 Subtypes and Groups

A total of 90 clinical specimens, ten of each Group M subtype (A, B, C, D, CRF01-AE, F, CRF02-AG, G) and of Group O, were tested with the RealTime HIV-1 assay and by two other approved HIV-1 quantitative assays referred to as Comparator 1 (FDA-approved version used) and Comparator 2 (CE-Marked version used). The numbers in parentheses are the number of specimens that had lower quantitation values by more than 1.00 log copies/mL when compared to RealTime HIV-1 assay.

GROUP/SUBTYPESNREALTIME DETECTEDCOMPARATOR 1 DETECTEDCOMPARATOR 2 DETECTED
M/Subtype A101010 (1)10 (1)
M/Subtype B101010 (0)10 (0)
M/Subtype C101010 (0)10 (0)
M/Subtype D101010 (0)10 (0)
M/Subtype AE101010 (0)10 (0)
M/Subtype F101010 (0)10 (0)
M/Subtype AG101010 (3)10 (1)
M/Subtype G101010 (2)10 (1)
Group O10100 (NA)7 (7)

N = number of specimens tested

Correlation to Comparator Assay

realtime-hiv-1-correlator-comparator image

A total of 301 specimens collected from HIV-1 infected patients were tested with the RealTime HIV-1 assay at three external sites and with the comparator method at a central laboratory site. The results from a total of 259 specimens that fell within the common assay dynamic range were analyzed by the Passing-Bablok linear regression method. 

 

Intended Use

The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) in whole blood spotted on cards as dried blood spots (DBS) (i.e. obtained via venipuncture or capillary blood) or human plasma from HIV-1 infected individuals. The Abbott RealTime HIV-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels. This assay is not intended to be used as a donor screening test for HIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection.

ORDERING INFO

Abbott RealTime HIV-1 Amplification Reagent Kit (plasma and DBS)(CE)
UNITORDER #GTIN
4 packs, 24 tests each02G31-01000884999045088
Abbott RealTime HIV-1 Calibrator Kit(CE)
UNITORDER #GTIN
12 sets of 2 levels02G31-07000884999001497
Abbott mDBS Buffer(CE)
UNITORDER #GTIN
4, 46 ml each09N02-00100884999044074
Abbott RealTime HIV-1 Amplification Reagent Kit(CE)
UNITORDER #GTIN
4 packs, 24 tests each02G31-09000884999001589
Abbott RealTime HIV-1 Control Kit(CE)
UNITORDER #GTIN
8 sets of 3 levels02G31-08000884999001534
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...